Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 47, 2019 - Issue 1
Submit an article Journal homepage
2,082
Views
8
CrossRef citations to date
0
Altmetric
Research Article

DPP-4 inhibitor anagliptin protects against hypoxia-induced cytotoxicity in cardiac H9C2 cells

Yunxiang Maa Southern Medical University Affiliated Fengxian Hospital, Shanghai, Shanghai, P.R. China;b Tengzhou Central People's Hospital, Tengzhou, Shandong Province, P.R. ChinaView further author information
,
Junkai Wangb Tengzhou Central People's Hospital, Tengzhou, Shandong Province, P.R. ChinaView further author information
,
Changhua Wangb Tengzhou Central People's Hospital, Tengzhou, Shandong Province, P.R. ChinaView further author information
,
Qiong Zhanga Southern Medical University Affiliated Fengxian Hospital, Shanghai, Shanghai, P.R. ChinaView further author information
,
Yannan Xua Southern Medical University Affiliated Fengxian Hospital, Shanghai, Shanghai, P.R. ChinaView further author information
,
Huajin Liua Southern Medical University Affiliated Fengxian Hospital, Shanghai, Shanghai, P.R. ChinaView further author information
,
Xia Xiangc Shanghai University of Medicine & Health Sciences, Shanghai, P.R. ChinaCorrespondence[email protected]
View further author information
&
Jiangwei Maa Southern Medical University Affiliated Fengxian Hospital, Shanghai, Shanghai, P.R. China;c Shanghai University of Medicine & Health Sciences, Shanghai, P.R. ChinaCorrespondence[email protected]
View further author information
 show all
Pages 3823-3831 | Received 01 Jun 2019, Accepted 01 Aug 2019, Published online: 26 Sep 2019

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Hai Zou, Ning Zhu & Shengqing Li. (2020) The emerging role of dipeptidyl-peptidase-4 as a therapeutic target in lung disease. Expert Opinion on Therapeutic Targets 24:2, pages 147-153.
Read now

Articles from other publishers (7)

Xiaohan Cui, Xiao Yun, Meiling Sun, Renzhi Li, Xiajie Lyu, Yuanxiang Lao, Xihu Qin & Wenbin Yu. (2022) HMGCL-induced β-hydroxybutyrate production attenuates hepatocellular carcinoma via DPP4-mediated ferroptosis susceptibility. Hepatology International 17:2, pages 377-392.
Crossref
Riffat Khanam, Arunima Sengupta, Dipankar Mukhopadhyay & Santanu Chakraborty. (2022) Identification of Adamts4 as a novel adult cardiac injury biomarker with therapeutic implications in patients with cardiac injuries. Scientific Reports 12:1.
Crossref
Zsófia Onódi, Tamás Visnovitz, Bernadett Kiss, Szabolcs Hambalkó, Anna Koncz, Bence Ágg, Barnabás Váradi, Viktória É. Tóth, Regina N. Nagy, Tamás G. Gergely, Dorottya Gergő, András Makkos, Csilla Pelyhe, Nóra Varga, Dóra Reé, Ágota Apáti, Przemyslaw Leszek, Tamás Kovács, Nándor Nagy, Péter Ferdinandy, Edit I. Buzás, Anikó Görbe, Zoltán Giricz & Zoltán V. Varga. (2022) Systematic transcriptomic and phenotypic characterization of human and murine cardiac myocyte cell lines and primary cardiomyocytes reveals serious limitations and low resemblances to adult cardiac phenotype. Journal of Molecular and Cellular Cardiology 165, pages 19-30.
Crossref
Yatong Zhang, Chao Li, Yifang Pei, Li Zheng, Xuelin Sun, Zinan Zhao & Shuanghu Wang. (2021) Trelagliptin ameliorates oxygen–glucose deprivation/reperfusion (OGD/R)-induced mitochondrial dysfunction and metabolic disturbance of endothelial cells. Human Cell 34:6, pages 1717-1726.
Crossref
Jingli Zhang & Lixia Liu. (2021) Anagliptin alleviates lipopolysaccharide‑induced inflammation, apoptosis and endothelial dysfunction of lung microvascular endothelial cells. Experimental and Therapeutic Medicine 22:6.
Crossref
Paweł Muszyński & Tomasz A. Bonda. (2021) Mitochondrial Dysfunction in Atrial Fibrillation—Mechanisms and Pharmacological Interventions. Journal of Clinical Medicine 10:11, pages 2385.
Crossref
Ilona Cuijpers, Anna‐Pia Papageorgiou, Paolo Carai, Melissa Herwig, Andreas Mügge, Thomas Klein, Nazha Hamdani, Elizabeth A. V. Jones & Stephane Heymans. (2020) Linagliptin prevents left ventricular stiffening by reducing titin cleavage and hypophosphorylation. Journal of Cellular and Molecular Medicine 25:2, pages 729-741.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.